Manoj Mathew
Pulmonary Disease · Phoenix, AZNPI 1467572107
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (43.7%), education and food and beverage — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by AstraZeneca at 50.8% of the total.
Across 184 payments — averaging $96.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$9K
- Intuitive Surgical$4K
- Medical Device Business Services, Inc.$2K
- Stryker$500
- Boehringer Ingelheim$375
- GSK$265
- plus $2K from 26 others
What the payments were for
- Consulting fees$5003%
- Speaking & faculty fees$7,75044%
- Travel & lodging$2,29013%
- Food & beverage$3,19618%
- Education$4,00023%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 47 | $9,002 |
| Intuitive Surgical | 3 | $4,378 |
| Medical Device Business Services, Inc. | 5 | $1,587 |
| Stryker | 1 | $500 |
| Boehringer Ingelheim | 18 | $375 |
| GSK | 18 | $265 |
| Sunovion Pharmaceuticals Inc. | 17 | $205 |
| Philips North America LLC | 8 | $168 |
| Mylan Specialty L.p. | 7 | $136 |
| Jazz Pharmaceuticals Inc. | 6 | $124 |
| Genentech USA, Inc. | 7 | $112 |
| Insmed, Inc. | 4 | $90 |
| Advanced Respiratory, Inc | 5 | $81 |
| AbbVie(2 entities) | 3 | $65 |
| Mayne Pharma Commercial LLC | 3 | $59 |
| Shire North American Group Inc | 3 | $57 |
| Merck | 3 | $53 |
| Regeneron Healthcare Solutions, Inc. | 3 | $52 |
| United Therapeutics Corporation | 3 | $51 |
| Sanofi | 3 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Actelion Pharmaceuticals US, Inc. | 1 | $39 |
| Electromed, Inc. | 3 | $36 |
| Harmony Biosciences LLC | 2 | $35 |
| Circassia Inc. | 2 | $34 |
| Johnson & Johnson | 1 | $33 |
| Getinge USA Sales, LLC | 1 | $33 |
| ZOLL Respicardia, Inc. | 1 | $19 |
| Veran Medical Technologies, Inc. | 1 | $15 |
| Pulmonx Corporation | 1 | $13 |
| Vapotherm Inc | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$8,358
- Da Vinci Surgical System$4,378
- MONARCH$1,533
- GLIDE SYSTEM$500
How this compares
$17,736 in reported general payments places this provider in the 85th percentile of 250 pulmonary disease providers in Arizona.
Other pulmonary disease in Phoenix
- Rajat WaliaPhoenix$748K
- Brian PorvinPhoenix$276K
- Abid KhokarPhoenix$262K
- Tony HodgesPhoenix$248K
- Mark GotfriedPhoenix$196K
- Rajeev SaggarPhoenix$161K
- Gregory AhearnPhoenix$144K
- Jagruti PatelPhoenix$141K
- Ali SaeedPhoenix$138K
- Ramit SharmaPhoenix$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.